Community-Centered Responses to Ebola in Urban Liberia: The View from Below

Abstract

BackgroundThe West African Ebola epidemic has demonstrated that the existing range of medical and epidemiological responses to emerging disease outbreaks is insufficient, especially in post-conflict contexts with exceedingly poor healthcare infrastructures. In this context, community-based responses have proven vital for containing Ebola virus disease (EVD) and shifting the epidemic curve. Despite a surge in interest in local innovations that effectively contained the epidemic, the mechanisms for community-based response remain unclear. This study provides baseline information on community-based epidemic control priorities and identifies innovative local strategies for containing EVD in Liberia.Methodology/Principal FindingsThis study was conducted in September 2014 in 15 communities in Monrovia and Montserrado County, Liberia – one of the epicenters of the Ebola outbreak. Findings from 15 focus group discussions with 386 community leaders identified strategies being undertaken and recommendations for what a community-based response to Ebola should look like under then-existing conditions. Data were collected on the following topics: prevention, surveillance, care-giving, community-based treatment and support, networks and hotlines, response teams, Ebola treatment units (ETUs) and hospitals, the management of corpses, quarantine and isolation, orphans, memorialization, and the need for community-based training and education. Findings have been presented as community-based strategies and recommendations for (1) prevention, (2) treatment and response, and (3) community sequelae and recovery. Several models for community-based management of the current Ebola outbreak were proposed. Additional findings indicate positive attitudes towards early Ebola survivors, and the need for community-based psychosocial support.Conclusions/SignificanceLocal communities’ strategies and recommendations give insight into how urban Liberian communities contained the EVD outbreak while navigating the systemic failures of the initial state and international response. Communities in urban Liberia adapted to the epidemic using multiple coping strategies. In the absence of health, infrastructural and material supports, local people engaged in self-reliance in order to contain the epidemic at the micro-social level. These innovations were regarded as necessary, but as less desirable than a well-supported health-systems based response; and were seen as involving considerable individual, social, and public health costs, including heightened vulnerability to infection.

Community-based health care is an essential component of a resilient health system: evidence from Ebola outbreak in Liberia

“…Although “no touch” iCCM guidelines sought to maintain continuity of services at the community level in a safe manner, the timing of this guidance and its associated training were very late. More proactive action is recommended to train all CHWs in basic infection control measures and provide them with the necessary protective equipment [8, 14, 20]. …”

Social Mobilization and Community Engagement Central to the Ebola Response in West Africa: Lessons for Future Public Health Emergencies

“…As the outbreak progressed beyond initial projections, and given the limitations of clinical approaches and weak local systems, pressure increased for community engagement and social mobilization to be central to changing behavior to prevent and control the outbreak 6 . According to one evaluation of this component of the global response 7 :…”

Post-Ebola reforms: ample analysis, inadequate action

“…23 Effective strategies for community mobilisation that had been developed in central Africa were not shared or applied quickly in west Africa. 24 Another failure was the lack of adequate research into the Ebola virus before the 2014 outbreak, which left the world without needed drugs, vaccines, and rapid diagnostic tests. Organisations such as the European Innovative Medicines Initiative and the US Biomedical Advanced Research and Development Authority have invested in these areas, but the US National Academy of Medicine report estimated an ongoing investment gap of $1bn a year.…”